Home/Filings/4/0001802768-25-000088
4//SEC Filing

Ho Carole 4

Accession 0001802768-25-000088

CIK 0001802768other

Filed

Jul 30, 8:00 PM ET

Accepted

Jul 31, 8:42 PM ET

Size

6.8 KB

Accession

0001802768-25-000088

Insider Transaction Report

Form 4
Period: 2025-07-31
Ho Carole
Director
Transactions
  • Award

    Class A Ordinary Shares

    2025-07-31+2,7522,752 total
  • Award

    Class A Ordinary Shares

    2025-07-31+5,8068,558 total
Footnotes (2)
  • [F1]Reflects an initial equity award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.
  • [F2]Reflects a pro-rated annual equity award of restricted stock units under the Plan that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Issuer

Royalty Pharma plc

CIK 0001802768

Entity typeother

Related Parties

1
  • filerCIK 0001724605

Filing Metadata

Form type
4
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 8:42 PM ET
Size
6.8 KB